| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8770994 | The Journal of Urology | 2018 | 9 Pages |
Abstract
Primary tumor location had no impact on progression-free or overall survival in patients with locally advanced or metastatic urothelial carcinoma treated with platinum based combination chemotherapy.
Keywords
methotrexate, vinblastine, doxorubicin and cisplatinM-VACBCARNUgemcitabine and cisplatinUTUCEORTCPFsprogression-free survivaloverall survivalCombinationDrug therapyHigh doseEuropean Organization for the Research and Treatment of CancerBladder cancerUrinary bladder neoplasmsurothelial carcinomaMortalityUrologic neoplasmsRadical nephroureterectomyUpper tract urothelial carcinomaUrothelium
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Marco Moschini, Shahrokh F. Shariat, Morgan Rouprêt, Maria De Santis, Joaquim Bellmunt, Cora N. Sternberg, Bertrand Tombal, Laurence Collette,